Sputum conversion among patients with pulmonary tuberculosis: Are there implications for removal of respiratory isolation?

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 4, 2007, Pages 794-798

  Fortún, Jesús ^a   Martín Dávila, Pilar ^a   Molina, Auxiliadora ^a   Navas, Enrique ^a   Hermida, José Manuel ^a   Cobo, Javier ^a   Gómez Mampaso, Enrique ^a   Moreno, Santiago ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Drug resistant tuberculosis; Infection control; Mycobacterium tuberculosis; Resistance

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; LUNG CAVITATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PREDICTION; SPAIN; SPUTUM ANALYSIS; SPUTUM CULTURE; SPUTUM SMEAR; SYMPTOM; TIME; TREATMENT DURATION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; AGED; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROBIOLOGY; MIDDLE AGED; PATIENT CARE; RISK FACTOR; SPUTUM; STATISTICAL MODEL;

ADULT; AGED; ANTITUBERCULAR AGENTS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; ISONIAZID; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PATIENT ISOLATION; RISK FACTORS; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 34250017511     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm025     Document Type: Article

References (13)

1. Malone JL, Ijaz K, Lambert L et al. Investigation of healthcare-associated transmission of Mycobacterium tuberculosis among patients with malignancies at three hospitals and at a residential facility. Cancer 2004; 101: 2713-21.
2. Kelley CL, Collins FM. Growth of a highly virulent strain of Mycobacterium tuberculosis in mice of differing susceptibility to tuberculous challenge. Tuberc Lung Dis 1999; 79: 367-70.
3. Fennelly KP, Martyny JW, Fulton KE et al. Cough-generated aerosols of Mycobacterium tuberculosis: A new method to study infectiousness. Am J Respir Crit Care Med 2004; 169: 604-9.
4. Jindani A, Aber VR, Edwards EA et al. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 1980; 121: 939-49.
5. Taylor Z, Nolan CM, Blumberg HM. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 2005; 54: RR- 12: 1-81.
6. Telzak EE, Fazal BA, Pollard CL et al. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis 1997; 25: 666-70.
7. Cruciani M, Malena M, Bosco O et al. The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: A meta-analysis. Clin Infect Dis 2001; 33: 1922-30.
8. Girardi E, Raviglione MC, Antonucci G et al. Impact of the HIV epidemic on the spread of other diseases: The case of tuberculosis. AIDS 2000; 14: Suppl 3: S47-56.
9. Anon. Control and prevention of tuberculosis in the United Kingdom: Code of practice 2000. Joint Tuberculosis Committee of the British Thoracic Society. Thorax 2000; 55: 887-901.
10. Wiselka M. 2006: A year for cautious optimism in tuberculosis. J Infect 2006; 53: 1-4.
11. Brindle R, Odhiambo J, Mitchison D. Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis. BMC Pulm Med 2001; 1: 2.
12. Iseman MD. An unholy trinity-three negative sputum smears and release from tuberculosis isolation. Clin Infect Dis 1997; 25: 671-2.
13. Caws M, Drobniewski FA. Molecular techniques in the diagnosis of Mycobacterium tuberculosis and the detection of drug resistance. Ann N Y Acad Sci 2001; 953: 138-45.